Aspiriant LLC’s Vanguard Morningstar Mid-Cap Growth ETF VOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$225K Sell
770
-1,058
-58% -$317K 0.01% 385
2026
Q2
$560K Hold
1,828
– – 0.01% 228
2026
Q1
$470K Sell
1,828
-570
-24% -$156K 0.01% 227
2025
Q4
$669K Hold
2,398
– – 0.02% 190
2025
Q3
$705K Hold
2,398
– – 0.02% 176
2025
Q2
$682K Hold
2,398
– – 0.02% 174
2025
Q1
$587K Buy
2,398
+570
+31% +$148K 0.02% 176
2024
Q4
$464K Hold
1,828
– – 0.02% 195
2024
Q3
$445K Hold
1,828
– – 0.02% 196
2024
Q2
$420K Buy
+1,828
New +$419K 0.02% 197
2023
Q2
– Sell
-2,427
Closed -$473K – 296
2023
Q1
$473K Buy
+2,427
New +$465K 0.02% 183

Other funds holding VOT

Aspiriant LLC's VOT Position: Q3 2026 in Review

Aspiriant LLC reduced its Vanguard Morningstar Mid-Cap Growth ETF (VOT) stake by 58% in Q3 2026, selling an estimated $317K and leaving 770 shares worth $225K. The position accounts for 0.01% of the portfolio, ranked #385.

Aspiriant LLC first reported a position in VOT in Q1 2023 and has held it in 11 quarters since. The position peaked at $705K in Q3 2025. 739 funds tracked by Wall St. Rank hold VOT as of Q3 2026.

  • Aspiriant LLC held 770 shares of Vanguard Morningstar Mid-Cap Growth ETF worth $225K as of Q3 2026.
  • Aspiriant LLC sold 1,058 Vanguard Morningstar Mid-Cap Growth ETF shares in Q3 2026, an estimated $317K.
  • Vanguard Morningstar Mid-Cap Growth ETF made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #385 holding.
  • Aspiriant LLC first reported a position in Vanguard Morningstar Mid-Cap Growth ETF in Q1 2023 and has held it in 11 quarters since.
  • Aspiriant LLC's Vanguard Morningstar Mid-Cap Growth ETF position peaked at $705K in Q3 2025.
  • 739 funds tracked by Wall St. Rank held Vanguard Morningstar Mid-Cap Growth ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.